The opioid overdose crisis is a major public health emergency, and naloxone is a life-saving reversal agent. Pharmacists, as accessible healthcare providers, are on the front lines of this crisis, a role that draws on knowledge from pharmacotherapy, law, and public health as taught throughout the PharmD curriculum ,
. This quiz will test your knowledge on the pharmacology of naloxone, the practical steps of overdose response, and the pharmacist’s critical role in naloxone dispensing and education.
1. The life-threatening event in an opioid overdose is primarily caused by:
- a. A massive increase in blood pressure.
- b. Severe respiratory depression.
- c. A sudden drop in blood glucose.
- d. Anaphylaxis.
Answer: b. Severe respiratory depression.
2. What is the mechanism of action of naloxone?
- a. It is a partial agonist at the mu-opioid receptor.
- b. It is a pure, competitive antagonist at the mu-opioid receptor.
- c. It stimulates the respiratory drive through a separate pathway.
- d. It increases the metabolism of opioids.
Answer: b. It is a pure, competitive antagonist at the mu-opioid receptor.
3. Which of the following is a classic sign of an opioid overdose?
- a. Dilated pupils (mydriasis)
- b. Rapid, deep breathing
- c. Pinpoint pupils (miosis) and unresponsiveness
- d. High fever
Answer: c. Pinpoint pupils (miosis) and unresponsiveness
4. A person administers a dose of intranasal naloxone to someone who has overdosed. What is the most important next step?
- a. To immediately administer a second dose.
- b. To leave the person alone to let the medication work.
- c. To call 911 immediately, as the effects of naloxone may wear off.
- d. To give the person a caffeinated beverage.
Answer: c. To call 911 immediately, as the effects of naloxone may wear off.
5. Naloxone has a _____ duration of action than most opioids like heroin or oxycodone.
- a. much longer
- b. slightly longer
- c. identical
- d. shorter
Answer: d. shorter
6. The “Pharmacology of Analgesics,” which covers opioids, is a lecture in which course?
- a. PHA5878C Patient Care 3
- b. PHA5104 Sterile Compounding
- c. PHA5703 Pharmacy Law and Ethics
- d. PHA5787C Patient Care 5
Answer: a. PHA5878C Patient Care 3
7. A person who is physically dependent on opioids is given naloxone. What is the expected outcome?
- a. No effect.
- b. A rapid and pleasant reversal of their “high.”
- c. The precipitation of an acute, severe withdrawal syndrome.
- d. A gradual return to consciousness over several hours.
Answer: c. The precipitation of an acute, severe withdrawal syndrome.
8. NarcanĀ® Nasal Spray should be administered by:
- a. Spraying half the dose in each nostril.
- b. Spraying the full dose into one nostril.
- c. Having the patient inhale deeply during administration.
- d. Spraying it into the mouth.
Answer: b. Spraying the full dose into one nostril.
9. The primary goal of administering naloxone during an overdose is to:
- a. Restore full consciousness and alertness.
- b. Induce withdrawal.
- c. Restore adequate spontaneous breathing.
- d. Punish the user for taking opioids.
Answer: c. Restore adequate spontaneous breathing.
10. Administering naloxone to a person who has NOT taken any opioids will result in:
- a. Severe respiratory depression.
- b. An opioid withdrawal syndrome.
- c. A state of euphoria.
- d. No significant pharmacological effect.
Answer: d. No significant pharmacological effect.
11. A pharmacist dispensing naloxone under a statewide standing order is acting in what capacity?
- a. A public health advocate.
- b. A dispenser of a legend drug.
- c. An educator.
- d. All of the above.
Answer: d. All of the above.
12. A “standing order” for naloxone allows a pharmacist to:
- a. Prescribe any controlled substance.
- b. Dispense naloxone to individuals at risk or their caregivers without a patient-specific prescription from a doctor.
- c. Refuse to dispense naloxone.
- d. Only dispense naloxone to healthcare professionals.
Answer: b. Dispense naloxone to individuals at risk or their caregivers without a patient-specific prescription from a doctor.
13. Which of the following is NOT a sign of opioid withdrawal?
- a. Nausea, vomiting, and diarrhea
- b. Yawning and sweating
- c. Muscle aches and agitation
- d. Respiratory depression
Answer: d. Respiratory depression
14. A key counseling point for a family member receiving a naloxone kit is:
- a. How to recognize the signs of an overdose.
- b. How to properly administer their specific naloxone product.
- c. The importance of calling 911 for every overdose.
- d. All of the above.
Answer: d. All of the above.
15. A patient who is revived with naloxone may become responsive and then unresponsive again 30-60 minutes later because:
- a. The naloxone dose was too high.
- b. The naloxone has a shorter half-life than the opioid, and the respiratory depression can return.
- c. The patient is having an allergic reaction.
- d. The naloxone has stopped working.
Answer: b. The naloxone has a shorter half-life than the opioid, and the respiratory depression can return.
16. The principles of pharmacy law are foundational to understanding naloxone access laws.
- a. True
- b. False
Answer: a. True
17. The “Pharmacotherapy of Pain” is a topic within the Patient Care 3 curriculum.
- a. True
- b. False
Answer: a. True
18. Which of the following patients should be offered a naloxone prescription?
- a. A patient on a high daily dose of opioids for chronic pain.
- b. A patient with a history of opioid use disorder.
- c. A patient taking an opioid concurrently with a benzodiazepine.
- d. All of the above.
Answer: d. All of the above.
19. Naloxone is a controlled substance.
- a. True
- b. False
Answer: b. False
20. An active learning session on pain management is part of the Patient Care 3 course.
- a. True
- b. False
Answer: a. True
21. A patient is found unresponsive after taking a large amount of alprazolam (a benzodiazepine). Will naloxone be effective?
- a. Yes, it reverses all sedative overdoses.
- b. No, naloxone only reverses the effects of opioids.
- c. Yes, but only if given intravenously.
- d. No, the correct reversal agent is epinephrine.
Answer: b. No, naloxone only reverses the effects of opioids.
22. “Good Samaritan” laws in many states are designed to:
- a. Punish bystanders who try to help.
- b. Protect individuals who act in good faith to provide emergency assistance from civil liability.
- c. Require every citizen to carry naloxone.
- d. Pay people for responding to an overdose.
Answer: b. Protect individuals who act in good faith to provide emergency assistance from civil liability.
23. The pharmacist’s role in promoting public health is a key objective in the IPPE curriculum.
- a. True
- b. False
Answer: a. True
24. An active learning session on pain is part of which course?
- a. PHA5878C Patient Care 3
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5878C Patient Care 3
25. A pharmacist providing naloxone and clean syringes to a person who injects drugs is participating in what type of public health strategy?
- a. Harm reduction
- b. Law enforcement
- c. A prescribing cascade
- d. A medication error
Answer: a. Harm reduction
26. The primary difference between Narcan (4 mg) and Kloxxado (8 mg) nasal sprays is the:
- a. Route of administration
- b. Active ingredient
- c. Dose of naloxone per spray
- d. Expiration date
Answer: c. Dose of naloxone per spray
27. A second dose of naloxone should be considered if:
- a. The patient wakes up immediately.
- b. The patient does not respond with improved breathing after 2-3 minutes.
- c. The patient becomes agitated.
- d. EMS has already arrived.
Answer: b. The patient does not respond with improved breathing after 2-3 minutes.
28. An active learning session on pain is part of which course module?
- a. Module 1: Introduction to Pain and Treatment Options
- b. Module 3: Dyslipidemia
- c. Module 5: Acute Coronary Syndrome
- d. Module 8: Introduction to Pulmonary Disease
Answer: a. Module 1: Introduction to Pain and Treatment Options
29. The purpose of a naloxone standing order is to:
- a. Increase barriers to accessing a life-saving medication.
- b. Decrease barriers to accessing a life-saving medication.
- c. Ensure only physicians can prescribe naloxone.
- d. Track all opioid users.
Answer: b. Decrease barriers to accessing a life-saving medication.
30. The law and ethics course PHA5703
would cover the state-specific regulations for dispensing naloxone.
- a. True
- b. False
Answer: a. True
31. Which of the following opioids has a very long half-life, meaning a patient who overdoses on it may require multiple doses of naloxone or a continuous infusion?
- a. Fentanyl
- b. Morphine
- c. Methadone
- d. Hydrocodone
Answer: c. Methadone
32. After administering naloxone and calling 911, the responder should place the person in what position if they are breathing on their own?
- a. The recovery position (on their side)
- b. Sitting upright
- c. Lying flat on their back
- d. In a comfortable chair
Answer: a. The recovery position (on their side)
33. The pharmacist’s counseling is critical to ensure that a caregiver knows:
- a. Naloxone is not a substitute for calling 911.
- b. The naloxone kit has an expiration date.
- c. The steps for administration.
- d. All of the above.
Answer: d. All of the above.
34. The increasing prevalence of illicitly manufactured fentanyl has led to:
- a. A decreased need for naloxone.
- b. A potential need for multiple or higher doses of naloxone to achieve reversal.
- c. Opioid overdoses that are not reversible.
- d. A decrease in the number of overdoses.
Answer: b. A potential need for multiple or higher doses of naloxone to achieve reversal.
35. A pharmacist dispensing naloxone should do so in a(n) ____ manner.
- a. judgmental and condescending
- b. rushed and dismissive
- c. empathetic and non-judgmental
- d. secretive
Answer: c. empathetic and non-judgmental
36. Buprenorphine is a partial opioid agonist. If a patient overdoses on buprenorphine, naloxone will:
- a. Have no effect.
- b. Require much higher doses to be effective due to buprenorphine’s high receptor affinity.
- c. Be more effective than for a full agonist.
- d. Cause a severe hypertensive crisis.
Answer: b. Require much higher doses to be effective due to buprenorphine’s high receptor affinity.
37. Opioid reversal is a key component of managing the risks associated with pain pharmacotherapy.
- a. True
- b. False
Answer: a. True
38. The “Pharmacotherapy of Pain” is a lecture in which course?
- a. PHA5878C Patient Care 3
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5878C Patient Care 3
39. A key part of the public health response to the opioid crisis is:
- a. Increasing access to naloxone.
- b. Increasing access to treatment for opioid use disorder.
- c. Preventing new cases of addiction through judicious prescribing.
- d. All of the above.
Answer: d. All of the above.
40. An active learning session covering pain management is part of which course?
- a. PHA5878C Patient Care 3
- b. PHA5163L Professional Skills Lab 3
- c. PHA5781 Patient Care I
- d. PHA5782C Patient Care 2
Answer: a. PHA5878C Patient Care 3
41. The term “opioid antagonist” means the drug:
- a. Binds to the opioid receptor and activates it.
- b. Binds to the opioid receptor and blocks it without causing an effect.
- c. Partially activates the opioid receptor.
- d. Is a type of opioid.
Answer: b. Binds to the opioid receptor and blocks it without causing an effect.
42. Which of the following is NOT a symptom of opioid overdose?
- a. Slow, shallow breathing
- b. Blue or gray skin, lips, and nails
- c. Pinpoint pupils
- d. Agitation and rapid speech
Answer: d. Agitation and rapid speech
43. A pharmacist’s role includes identifying patients at risk for overdose and proactively offering naloxone.
- a. True
- b. False
Answer: a. True
44. After a successful reversal with naloxone, the patient should be monitored for at least how long by medical professionals?
- a. 30 minutes
- b. 1 hour
- c. 2-4 hours
- d. They can be immediately discharged.
Answer: c. 2-4 hours
45. What is the primary reason it is critical to call 911 even if naloxone successfully revives someone?
- a. The naloxone can wear off, and the person can become unresponsive again.
- b. The person needs medical evaluation for other complications of the overdose.
- c. The person may need access to treatment for opioid use disorder.
- d. All of the above.
Answer: d. All of the above.
46. “Naloxone co-prescribing” refers to the practice of:
- a. Prescribing two different naloxone formulations.
- b. Prescribing naloxone at the same time a high-risk opioid prescription is written.
- c. Prescribing naloxone with an antibiotic.
- d. A patient asking for naloxone.
Answer: b. Prescribing naloxone at the same time a high-risk opioid prescription is written.
47. A pharmacist is the most accessible healthcare professional for many people, making them critical for naloxone distribution.
- a. True
- b. False
Answer: a. True
48. An active learning session on pain is part of which course module?
- a. Module 1: Introduction to Pain and Treatment Options
- b. Module 2: Hypertension
- c. Module 4: Ischemic Heart Disease
- d. Module 7: Arrhythmias
Answer: a. Module 1: Introduction to Pain and Treatment Options
49. The overall goal of widespread naloxone access is to:
- a. Encourage opioid use.
- b. Reduce deaths from opioid overdose.
- c. Increase pharmacy profits.
- d. Punish people who use drugs.
Answer: b. Reduce deaths from opioid overdose.
50. The ultimate reason to learn about opioid reversal is to:
- a. Be equipped with the knowledge to save a life in an emergency overdose situation.
- b. Pass the pain management module.
- c. Fulfill a legal requirement.
- d. Be able to counsel on the risks of naloxone.
Answer: a. Be equipped with the knowledge to save a life in an emergency overdose situation.

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com